Salix Settles With Novel Over Generic MoviPrep

Law360, New York (August 30, 2010, 4:35 PM EDT) -- Salix Pharmaceuticals Ltd. and Norgine BV have reached a settlement with Novel Laboratories Inc. that will allow the generics maker to launch its own version of colon-cleansing medicine MoviPrep no later than 2018.

The agreement, which still requires court approval, would resolve a patent infringement suit pending against Somerset, N.J.-based Novel in the U.S. District Court for the District of New Jersey, Salix said Monday in a statement.

Salix and Amsterdam-based Norgine sued the generics maker in May 2008 after it submitted an abbreviated new drug...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.